Lv11
30 积分 2023-11-03 加入
An orphan to the rescue of obesity and steatotic liver?
7小时前
待确认
Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR
7小时前
已完结
Identification and characterization of novel developmentally regulated neural-specific proteins, BRINP family
25天前
已完结
Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide
27天前
已完结
GPR75: A Newly Identified Receptor for Targeted Intervention in the Treatment of Obesity and Metabolic Syndrome
29天前
已完结
GPR75: An exciting new target in metabolic syndrome and related disorders
29天前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
30天前
已完结
Obesity drugs aren’t always forever. What happens when you quit?
30天前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
1个月前
已完结
Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential
1个月前
已完结
皖公网安备34019202002308
